Preparation of Cas9 Ribonucleoproteins for Genome Editing

被引:3
作者
Lin, Sheng-Wei [1 ,2 ]
Viet Quoc Nguyen [1 ]
Lin, Steven [1 ,2 ]
机构
[1] Acad Sinica, Inst Biol Chem, Taipei, Taiwan
[2] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan
来源
BIO-PROTOCOL | 2022年 / 12卷 / 10期
关键词
CRISPR; Cas9; RNP; sgRNA; In vitro transcription;
D O I
10.21769/BioProtoc.4420
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Genome editing by the delivery of pre-assembled Cas9 ribonucleoproteins (Cas9 RNP) is an increasingly popular approach for cell types that are difficult to manipulate genetically by the conventional plasmid and viral methods. Cas9 RNP editing is robust, precise, capable of multiplexing, and free of genetic materials. Its transient presence in cells limits residual editing activity. This protocol describes the preparation of recombinant Streptococcus pyogenes Cas9 (SpCas9) protein by heterologous expression and purification from Escherichia coli, and the synthesis of CRISPR guide RNA by in vitro transcription and PAGE purification. SpCas9 is the first CRISPR Cas9 discovered (Jinek et al., 2012) and is also one of the most characterized Cas enzymes for genome editing applications. Using this formulation of Cas9 RNP, we have demonstrated highly efficient genome editing in primary human T and natural killer (NK) cells by electroporation, and in fungi and plants by polyethylene glycol-mediated transformation. Our protocol of Cas9 RNP preparation is consistent and straightforward to adopt for genome editing in other cell types and organisms.
引用
收藏
页数:27
相关论文
共 50 条
  • [31] CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells
    Bloomer, Hanan
    Khirallah, Jennifer
    Li, Yamin
    Xu, Qiaobing
    ADVANCED DRUG DELIVERY REVIEWS, 2022, 181
  • [32] CRISPR/Cas9 for plant genome editing: accomplishments, problems and prospects
    Joseph W. Paul
    Yiping Qi
    Plant Cell Reports, 2016, 35 : 1417 - 1427
  • [33] Genome editing in the mouse brain with minimally immunogenic Cas9 RNPs
    Stahl, Elizabeth C.
    Sabo, Jennifer K.
    Kang, Min Hyung
    Allen, Ryan
    Applegate, Elizabeth
    Kim, Shin Eui
    Kwon, Yoonjin
    Seth, Anmol
    Lemus, Nicholas
    Salinas-Rios, Viviana
    Soczek, Katarzyna M.
    Trinidad, Marena
    Vo, Linda T.
    Jeans, Chris
    Wozniak, Anna
    Morris, Timothy
    Kimberlin, Athen
    Foti, Thomas
    Savage, David F.
    Doudna, Jennifer A.
    MOLECULAR THERAPY, 2023, 31 (08) : 2422 - 2438
  • [34] Efficient multiplex genome editing by CRISPR/Cas9 in common wheat
    Li, Jihu
    Zhang, Shujuan
    Zhang, Rongzhi
    Gao, Jie
    Qi, Yiping
    Song, Guoqi
    Li, Wei
    Li, Yulian
    Li, Genying
    PLANT BIOTECHNOLOGY JOURNAL, 2021, 19 (03) : 427 - 429
  • [35] Versatile CRISPR/Cas9 Systems for Genome Editing in Ustilago maydis
    Wege, Sarah-Maria
    Gejer, Katharina
    Becker, Fabienne
    Bolker, Michael
    Freitag, Johannes
    Sandrock, Bjorn
    JOURNAL OF FUNGI, 2021, 7 (02) : 1 - 11
  • [36] Genome modification by CRISPR/Cas9
    Ma, Yuanwu
    Zhang, Lianfeng
    Huang, Xingxu
    FEBS JOURNAL, 2014, 281 (23) : 5186 - 5193
  • [37] Improving the Genome Editing Efficiency of CRISPR/Cas9 in Melon and Watermelon
    Wang, Zhuanrong
    Wan, Lili
    Ren, Jian
    Zhang, Na
    Zeng, Hongxia
    Wei, Jiaqi
    Tang, Mi
    CELLS, 2024, 13 (21)
  • [38] Application of CRISPR/Cas9 genome editing to the study and treatment of disease
    Pellagatti, Andrea
    Dolatshad, Hamid
    Valletta, Simona
    Boultwood, Jacqueline
    ARCHIVES OF TOXICOLOGY, 2015, 89 (07) : 1023 - 1034
  • [39] Advances in CRISPR/Cas9 Genome Editing for the Treatment of Muscular Dystrophies
    Fatehi, Sina
    Marks, Ryan M.
    Rok, Matthew J.
    Perillat, Lucie
    Ivakine, Evgueni A.
    Cohn, Ronald D.
    HUMAN GENE THERAPY, 2023, 34 (9-10) : 388 - 403
  • [40] Efficient genome editing using modified Cas9 proteins in zebrafish
    Dorner, Laura
    Stratmann, Benedikt
    Bader, Laura
    Podobnik, Marco
    Irion, Uwe
    BIOLOGY OPEN, 2024, 13 (04):